ISRCTN11970082已完成未知
An academic multicentre open-label single-arm study to record the efficacy of indomethacin among confirmed COVID-19 patients with mild and moderate symptoms
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 250
研究概览
简要总结
2020 non-peer-reviewed results in preprint https://doi.org/10.1101/2020.12.14.20245266 (added 17/03/2021)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Age 21 to 90 years
- •2. RT-PCR positive
- •3. Hospitalised patients
- •4. The case criteria for the study: LFT and KFT normal
排除标准
- •1. Hypersensitivity/allergy to drug
- •2. Gastritis
- •3. Recent heart attack
- •4. Severe asthma
- •5. Acute kidney Injury
- •6. Patients on immunosuppressants
研究者
相似试验
已完成
不适用
A study to investigate the delivery of nicotine in the blood stream from two variants of e-cigarette devices and a conventional cigaretteISRCTN55307091British American Tobacco (Investments) Ltd24
进行中（未招募）
不适用
The Vesalio NeVa Stent Retriever Study for Treatment of Large Vessel Occlusion StrokesAcute Ischemic StrokeNCT03927001Vesalio150
进行中（未招募）
不适用
The Vesalio NeVa Stent Retriever Study for Treatment of Large Vessel Occlusion Strokes: CLEAR StudyAcute Ischemic StrokeNCT04514562Vesalio120
进行中（未招募）
4 期
A study to evaluate the efficacy and safety of Fixed Dose Combination of Glycopyrronium, Formoterol Fumarate, Budesonide in patients with chronic obstructive pulmonary disease.CTRI/2023/10/058791upin Limited
进行中（未招募）
1 期
Clinical trial in patients with advanced breast cancer (hormone receptor-positive, HER2-negative) receiving palbociclib and standard therapy with an aromatase inhibitor or fulvestrant after prior endocrine therapy.The study population includes postmenopausal patients with advanced (locally recurrent, inoperable and/or metastatic), HR+, HER2- breast cancer. For peri-/premenopausal patients, endocrine therapy has to be combines with a luteinizing hormone-releasinghormone (LRHR) agonist.MedDRA version: 21.1Level: LLTClassification code 10072737Term: Advanced breast cancerSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 100000004864MedDRA version: 23.0Level: LLTClassification code 10070575Term: Estrogen receptor positive breast cancerSystem Organ Class: 100000004864EUCTR2015-001603-32-DEiOMEDICO AG360